glp-1 cardiovascular outcomes news today and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Cardiac Trials | Lowering CV
Description
This isn't just a new drug
Key Effects: Kidney-Focused Regulation Acts on renal proximal tubules independently of insulin
Chen: "Thats a common misconception
2024 Oct 14;120(12):1427-1441
